Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90824552 | 9082455 | 2 | F | 20160809 | 20130218 | 20160816 | PER | US-PFIZER INC-2013060183 | PFIZER | 21.00 | YR | F | Y | 49.89000 | KG | 20160816 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 90824552 | 9082455 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, 1X/DAY | U | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 90824552 | 9082455 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 225 MG, 1X/DAY | U | 20699 | 225 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 90824552 | 9082455 | 3 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 150 MG, 1X/DAY | U | 20699 | 150 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 90824552 | 9082455 | 4 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, 1X/DAY | U | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 90824552 | 9082455 | 5 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 37.5 MG, 1X/DAY | U | 20699 | 37.5 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 90824552 | 9082455 | 6 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, 1X/DAY | U | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | QD | ||||||
| 90824552 | 9082455 | 7 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | UNK | U | 20699 | PROLONGED-RELEASE CAPSULE | |||||||||
| 90824552 | 9082455 | 8 | C | VALIUM | DIAZEPAM | 1 | 5 MG, 2X/DAY | 0 | 5 | MG | BID | ||||||||
| 90824552 | 9082455 | 9 | C | VALIUM | DIAZEPAM | 1 | 15 MG, DAILY | 0 | 15 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 90824552 | 9082455 | 1 | Post-traumatic stress disorder |
| 90824552 | 9082455 | 2 | Anxiety |
| 90824552 | 9082455 | 3 | Panic attack |
| 90824552 | 9082455 | 8 | Depression |
| 90824552 | 9082455 | 9 | Panic attack |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 90824552 | 9082455 | Blood pressure abnormal | |
| 90824552 | 9082455 | Blood sodium decreased | |
| 90824552 | 9082455 | Diarrhoea | |
| 90824552 | 9082455 | Dizziness | |
| 90824552 | 9082455 | Drug ineffective | |
| 90824552 | 9082455 | Energy increased | |
| 90824552 | 9082455 | Fatigue | |
| 90824552 | 9082455 | Fear | |
| 90824552 | 9082455 | Feeling abnormal | |
| 90824552 | 9082455 | Hypersomnia | |
| 90824552 | 9082455 | Influenza like illness | |
| 90824552 | 9082455 | Malaise | |
| 90824552 | 9082455 | Mania | |
| 90824552 | 9082455 | Nausea | |
| 90824552 | 9082455 | Paraesthesia | |
| 90824552 | 9082455 | Product quality issue | |
| 90824552 | 9082455 | Vomiting | |
| 90824552 | 9082455 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 90824552 | 9082455 | 1 | 200103 | 0 | ||
| 90824552 | 9082455 | 6 | 2001 | 0 |